Dermatitis News

For some atopic dermatitis patients treated with tralokinumab who do not reach clear or almost clear skin, clinically meaningful results can still occur.

Depressive episodes are closely correlated with and fluctuate with atopic dermatitis severity, according to details from a study published in the Journal of the American Academy of Dermatology.

Healio was on site at this year’s American Academy of Dermatology Annual Meeting, covering a range of important dermatology news, including updates to atopic dermatitis, psoriasis and hair disorders.

Patients with atopic dermatitis, especially those with more severe forms of the disease, are at increased risk for multiple autoimmune conditions, according to a study published in The Journal of Allergy and Clinical Immunology.

A dosing change from once a week to every other week did not diminish the long-term efficacy or safety of dupilumab in certain patients with atopic dermatitis, according to analysis findings.

Immunosuppressive drugs for the treatment of atopic dermatitis did not reduce protection conferred by messenger RNA COVID-19 vaccination, according to a study.

Data published in the American Journal of Clinical Dermatology showed that Opzelura cream was a well-tolerated and effective topical treatment for patients with atopic dermatitis.

Regular use of bleach baths modestly improved atopic dermatitis severity among most patients with a good safety profile, according to a systematic review and meta-analysis published in Annals of Allergy, Asthma & Immunology.

Cibinqo safely and effectively treated moderate to severe atopic dermatitis among patients regardless of any previous treatment with Dupixent, according to data published in the Journal of the American Academy of Dermatology.

A small increase in dementia incidence was found in older patients with atopic eczema, according to a study.